Kodiak Sciences Inc reports that BlackRock, Inc. beneficially owned 3,273,386 shares of Common Stock, representing 5.3% of the class as of 03/31/2026. The filing shows BlackRock has sole voting power for 3,221,479 shares and sole dispositive power for 3,273,386 shares. The schedule is signed by a BlackRock managing director on 04/27/2026.
Positive
None.
Negative
None.
Insights
BlackRock holds a 5.3% stake in Kodiak Sciences as of 03/31/2026.
BlackRock's Schedule 13G lists 3,273,386 shares beneficially owned and reports full dispositive control over those shares, with 3,221,479 shares subject to sole voting power. This identifies BlackRock as a substantial institutional holder.
Because the filing is a Schedule 13G, it reflects a passive investment filing; the filing does not indicate active control or changes to Kodiak's operations. Subsequent filings would show material changes in ownership or voting intent.
Key Figures
Shares beneficially owned:3,273,386 sharesPercent of class:5.3%Sole voting power:3,221,479 shares+1 more
4 metrics
Shares beneficially owned3,273,386 sharesAmount beneficially owned as of 03/31/2026
Percent of class5.3%Percent of common stock reported owned
Sole voting power3,221,479 sharesSole power to vote or to direct the vote
Sole dispositive power3,273,386 sharesSole power to dispose or to direct the disposition
Key Terms
Schedule 13G, beneficially owned, sole dispositive power, sole voting power
4 terms
Schedule 13Gregulatory
"In accordance with SEC Release No. 34-39538 (January 12, 1998), this reflects"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially ownedfinancial
"Amount beneficially owned: 3273386 (b) Percent of class: 5.3 %"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive powerregulatory
"Sole power to dispose or to direct the disposition of: 3273386"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
sole voting powerregulatory
"Sole power to vote or to direct the vote: 3221479"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
BlackRock reports beneficial ownership of 3,273,386 shares, equal to 5.3% of Kodiak Sciences' common stock as of 03/31/2026. The filing is a Schedule 13G showing institutional passive ownership.
Does BlackRock control voting for those KOD shares?
BlackRock reports sole voting power for 3,221,479 shares and sole dispositive power for 3,273,386 shares. This indicates BlackRock can direct votes and dispositions on most shares it reports.
What type of SEC filing is this for KOD?
This is a Schedule 13G, a passive institutional ownership statement filed under SEC rules. It reports beneficial ownership without asserting an active intent to influence corporate control.
What are the important dates in the filing?
The ownership amount is reported as of 03/31/2026 and the Schedule 13G is signed on 04/27/2026 by a BlackRock managing director, per the filing's signature block.
Does the filing identify other persons with >5% ownership?
The filing states that various persons have rights to dividends or proceeds but that no single other person's interest exceeds 5% of the class, per the Item 6 disclosure.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
KODIAK SCIENCES INC
(Name of Issuer)
Common Stock
(Title of Class of Securities)
50015M109
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
50015M109
1
Names of Reporting Persons
BlackRock, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
3,221,479.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
3,273,386.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,273,386.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.3 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
KODIAK SCIENCES INC
(b)
Address of issuer's principal executive offices:
1250 PAGE MILL RD PALO ALTO CA 94304
Item 2.
(a)
Name of person filing:
BlackRock, Inc.
In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)
Address or principal business office or, if none, residence:
BlackRock, Inc., 50 Hudson Yards New York, NY 10001
(c)
Citizenship:
See Item 4 of Cover Page
(d)
Title of class of securities:
Common Stock
(e)
CUSIP Number(s):
50015M109
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
3273386
(b)
Percent of class:
5.3 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
3221479
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
3273386
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of KODIAK SCIENCES INC. No one person's interest in the common stock of KODIAK SCIENCES INC is more than five percent of the total outstanding common shares.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Exhibit 99
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.